<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Research Contracts</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A9FE2CA7-E55A-408B-B358-E63E9B2783B0"><gtr:id>A9FE2CA7-E55A-408B-B358-E63E9B2783B0</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:otherNames>Anne</gtr:otherNames><gtr:surname>Weiss</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3F774323-0469-4DDF-82AD-CFFC512C6285"><gtr:id>3F774323-0469-4DDF-82AD-CFFC512C6285</gtr:id><gtr:firstName>Richard John</gtr:firstName><gtr:surname>Hayes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3CC9C285-F7E1-46F6-9DC4-AD451FFBE99B"><gtr:id>3CC9C285-F7E1-46F6-9DC4-AD451FFBE99B</gtr:id><gtr:firstName>Deborah</gtr:firstName><gtr:surname>Watson-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400456"><gtr:id>B8BC89BE-F360-4DCC-BB6D-245A0FA6C2DF</gtr:id><gtr:title>Effect of herpes suppressive therapy on HIV genital shedding among high risk women in Tanzania</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400456</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>414659</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Dissemination in Tanzania</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>29B9B64C-C746-4016-BAC7-1629E87C26A4</gtr:id><gtr:impact>Half day meeting facilitiated by LSHTM, the African Medical and Research Foundation (AMREF) and the National Institute of Medical Research, Tanzania (NIMR) to discuss implications of the trial results

Discussions with stakeholders to inform interpretation of results</gtr:impact><gtr:outcomeId>84E324796A8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>14500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Flexible Travel Award</gtr:description><gtr:end>2007-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3D0F033F-7CBA-4FA1-ADAA-D5AE28F824FB</gtr:id><gtr:outcomeId>HFb56kn31SC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>03129F36-CE08-4CE0-B77C-04BB712D7DBC</gtr:id><gtr:title>A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in Tanzania.</gtr:title><gtr:parentPublicationTitle>AIDS care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d73343431b14a754b31436dc23cd851"><gtr:id>2d73343431b14a754b31436dc23cd851</gtr:id><gtr:otherNames>Plummer ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0954-0121</gtr:issn><gtr:outcomeId>HireMwUra4V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEE42C5B-B1C0-42A8-9148-380646232610</gtr:id><gtr:title>No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17206a93cc42c912faf62768366872fb"><gtr:id>17206a93cc42c912faf62768366872fb</gtr:id><gtr:otherNames>LeGoff J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>sHuSVf9jDbN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11F7885C-D004-4FE0-B49B-92B36A77A845</gtr:id><gtr:title>Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>Fu689tqAiZ1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EBA5B21-1F29-4879-AF6C-FE7A92570E54</gtr:id><gtr:title>Correlates of HIV-1 genital shedding in Tanzanian women.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41cb267e09762c4a4206ce102aaca910"><gtr:id>41cb267e09762c4a4206ce102aaca910</gtr:id><gtr:otherNames>Tanton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>D90E262C_BD90E262C_B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D60E875-8AE4-4EB4-9ABA-8FA625C80180</gtr:id><gtr:title>Time to refocus on HSV interventions for HIV prevention?</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41cb267e09762c4a4206ce102aaca910"><gtr:id>41cb267e09762c4a4206ce102aaca910</gtr:id><gtr:otherNames>Tanton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>HuHyWXMUEFg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0886CC8A-2FA3-4240-92D3-0E9ED717CBF3</gtr:id><gtr:title>Influence of storage temperature on the stability of HIV-1 RNA and HSV-2 DNA in cervicovaginal secretions collected by vaginal washing.</gtr:title><gtr:parentPublicationTitle>Journal of virological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51046365ea35b0e8108691160b76051b"><gtr:id>51046365ea35b0e8108691160b76051b</gtr:id><gtr:otherNames>Legoff J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0166-0934</gtr:issn><gtr:outcomeId>9FCBF3AFA7A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9EDA70D-8E33-429C-84E4-1888CCD55234</gtr:id><gtr:title>Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41cb267e09762c4a4206ce102aaca910"><gtr:id>41cb267e09762c4a4206ce102aaca910</gtr:id><gtr:otherNames>Tanton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>agMii8KipWK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0FD8C96-5470-43B5-B65D-8DB446B39711</gtr:id><gtr:title>Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41cb267e09762c4a4206ce102aaca910"><gtr:id>41cb267e09762c4a4206ce102aaca910</gtr:id><gtr:otherNames>Tanton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>rk2Y4hxhWBP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8FC7CA0-55EE-46FE-A414-5C5E3881CF62</gtr:id><gtr:title>Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>ePeyRHSbsNW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D42426DC-EE81-4A25-A13C-700EEC95F8EC</gtr:id><gtr:title>Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania.</gtr:title><gtr:parentPublicationTitle>Contemporary clinical trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-7144</gtr:issn><gtr:outcomeId>5932F88AB6F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88567B9D-97D9-4A96-A64B-FD2A3BC534DC</gtr:id><gtr:title>Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b78663db318ad79a3cf319b9bc1788c"><gtr:id>6b78663db318ad79a3cf319b9bc1788c</gtr:id><gtr:otherNames>Baisley K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>D01D1B0942F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400456</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>4F7FE31F-D266-4FE9-9BAB-3D21E9B789BA</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.3  Nutrition and chemoprevention</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>